StockData
Lantern Pharma Inc. logo

Lantern Pharma Inc. (LTRN) stock

LTRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 5/30
$0.36−0.02 (-6.17%)

Close on Nov 17, 2026Market cap $4.67MP/E –Yield –

Lantern Pharma enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Lantern Pharma's enterprise value was -$1.22M on Nov 11, 2026, against $27.60M a year earlier. Over the last 5 years it ranged from -$20.99M to $53.04M, with a median of $7.53M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$1.22M-105.8%
2025Dec 31, 2025$21.09M+232.1%
2024Dec 31, 2024$6.35M+298.4%
2023Dec 29, 2023$1.59M-79.4%
2022Dec 30, 2022$7.75M-49.8%
2021Dec 31, 2021$15.44M-84.4%
2020Dec 31, 2020$98.89M–

More Lantern Pharma figures

See a number that looks wrong?